Attana AB (publ) (NGM:ATANA)
0.0030
0.00 (0.00%)
At close: Aug 14, 2026
Attana AB Company Description
Attana AB (publ) operates as a life science and diagnostics company in Sweden.
The company offers contract research services; Attana Cell 250, an analytical instrument; biosensor chips, reagents, and buffers; and Attana Virus Analytics, a diagnostic application.
Its products and services are used in antibody development, vaccine development, cell-based assays, immunogenicity studies, infectious diseases, biological interaction analysis, drug discovery and development, and translational research applications.
The company was founded in 2002 and is based in Sollentuna, Sweden.
Attana AB (publ)
| Country | Sweden |
| Founded | 2002 |
| Industry | Commercial Physical and Biological Research |
| Employees | 6 |
| CEO | Anna Hellergård |
Contact Details
Address: Engelbrekts väg 6 Sollentuna, 191 62 Sweden | |
| Phone | 46 8 41 02 00 00 |
| Website | attana.com |
Stock Details
| Ticker Symbol | ATANA |
| Exchange | Nordic Growth Market |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Anna Hellergård | Chief Executive Officer |
| Cornelia Ekstrom | Chief Financial Officer |